Middle East Healthcare (Saudi German Health)السعودي الألماني الصحية
- Price
- 32.68 SAR
- Fair value
- 27.55 SAR
- Discount to fair value
- −19%
- Mkt cap
- 3.01B
- P/E
- 10.7×
- P/B
- 1.85×
- EV
- 5.42B
- ROE
- 17.3%
- Net margin
- 9.8%
Current price32.68SAR
Fair value (est., median)27.55SAR
UndervaluedFair valueOvervalued
+18.6% above fair valueWould need to fall ~15.7% to reach fair value.
Median ofDCF 81.04Graham 30.65Residual Income 24.45Earnings Power 22.51
Health Check
57.9
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Strong return on equity (17.3%).
- Above-average growth expected.
Risks
- Trades 18.6% above estimated fair value.
- Stretched balance sheet / elevated debt.
- Low fair-value confidence — methods disagree or data is thin.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for detailsDemo series
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 4 years · FY2021–FY2024
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | TTM'26 |
|---|---|---|---|---|---|
| Revenue | 1.87B | 2.15B | 2.65B | 2.88B | — |
| Net Income | 17.20M | 75.18M | 17.04M | 282.00M | 167.45M |
| Net Margin | 0.9% | 3.5% | 0.6% | 9.8% | — |
| Operating Cash Flow | 76.62M | 76.02M | 191.08M | 766.00M | — |
| OCF Margin | 4.1% | 3.5% | 7.2% | 26.6% | — |
| Capital Expenditure | 417.51M | 249.53M | 232.37M | 479.32M | — |
| Free Cash Flow | -340.89M | -173.50M | -41.29M | 286.68M | — |
| FCF Margin | -18.2% | -8.1% | -1.6% | 9.9% | — |
| FCF Conversion | -1,981.8% | -230.8% | -242.3% | 101.7% | — |
| EPS (Diluted) | 0.19/sh | 0.82/sh | 0.19/sh | 3.06/sh | 1.82/sh |
| Dividend / Share | — | — | — | — | — |
Dividend return (if you buy today)
This company doesn’t currently pay a dividend, so there’s no income return to project. The fair-value gauge above covers the price side.
Dividend history
Dividend / share & historical yield (SAR).
No dividend history — this company doesn’t currently pay a dividend.
Valuation breakdown
Fair value = median of the applicable methods (DCF، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
81.04
Dividend Discount Model
Excluded — company pays no dividend
N/A
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
30.65
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
24.45
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
22.51
DCF only is anchored on FY2024 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)27.55
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 8.07%
- CAPM cost of equity
- 10.50%
- Risk-free rate
- 4.50%
- Equity risk premium
- 6.00%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 5
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Analyst Price Targets
1 houseHistorical — last published analyst views, not a current target.
Hajras fair value: 27.55
Aljazira Capital
as of 2023-02-28 · Middle East Healthcare (MEH) - Results Flash Note Q4-22
Hold
30.00
—
Wealth simulator
What if you'd invested in Middle East Healthcare (Saudi German Health) regularly?
Starting year
- Invested
- 1K/yr · 1K total(2026 → today · 1 yrs)
- your value today is
- 1K SAR
- Total return
- 0.0%(0.0% Dividends · 0.0% Capital gain)
- Annualised (IRR)
- +0.0%
Invested1KSAR
Dividends0SAR
Capital gain0SAR
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.